New
VR Foundation joins HCPLive® Strategic Alliance Partnership Program to provide better care for vitiligo patients. This multimedia platform is dedicated to providing physicians with up-to-date information on the disease and treatments.
"This synergy will allow us continue putting forth leading disease-specific resources to guide physicians in providing the best possible care to the patients they serve," said Mike Hennessy Jr., president and CEO of MJH Life Sciences™, parent company of HCPLive®.
FAQOther Questions
- What is vitiligo?
Vitiligo (pronounced vit-ill-EYE-go) is a generally unpredictable skin disease that causes a gradual loss of skin color and overlying hair on different parts of the body. Cont...
- Will it spread?
Vitiligo's progression and response to treatment can vary significantly among individuals, making it a particularly unpredictable skin condition. Based on the VALIANT study, her...
- How Vitiligo Changes with Age?
Vitiligo, a condition characterized by the loss of skin pigmentation, can affect individuals at any stage of life. While it often appears before the age of 20, its progression a...
Though it is not always easy to treat vitiligo, there is much to be gained by clearly understanding the diagnosis, the future implications, treatment options and their outcomes.
Many people deal with vitiligo while remaining in the public eye, maintaining a positive outlook, and having a successful career.
Copyright (C) Bodolóczki JúliaBy taking a little time to fill in the anonymous questionnaire, you can help researchers better understand and fight vitiligo.